Table 2.
Procedural details and outcomes
| re-PED | re-VRD | Total | p value | |
|---|---|---|---|---|
| Cases | 11 (55) | 9 (45) | 20 | |
| Procedural success | 11 (100) | 9 (100) | 20 (100) | |
| Duration since latest Tx, months | 18.1±11.4 (3.2–42.6) | 87.5±52 (8.3–155.2) | 47.3±48.57 (3.2–155.2) | 0.0002 |
| Access & catheters | ||||
| Average #PED used Coverage | 1 (1–1) | 1.9 (1–3) | 1.4 (1–3) | 0.0025 |
| Distal coverage | 9 (82) | 8 (89) | 17 (85) | |
| Proximal coverage | 9 (82) | 9 (100) | 18 (90) | |
| Case characteristics | ||||
| Flouro time, min | 33.7±16.2 (12.2–62.6) | 59.1±31.9 (22.9–117.8) | 45.1±27.1 (12.2–117.8) | 0.02 |
| Radiation exposure, mGy | 2,132±1,061 (1,218–4,797) | 3,812±2,551 (1,274–8572) | 2,888±2,017 (1,218–8572) | 0.03 |
| Adjunct coil deployment | 0 (0) | 1 (11) | 1 (5) | 0.45 |
| Vasospasm (verapamil infusion) | 1 (9) | 1 (11) | 2 (10) | 1.00 |
| Balloon angioplasty | 3 (27) | 5 (56) | 8 (40) | 0.36 |
| PED thrombosis | 0 (0) | 2 (22) | 2 (10) | 0.19 |
| Aneurysm occlusion | ||||
| DSA follow-up | 9 (82) | 7 (78) | 16 (80) | 1.00 |
| Time to DSA follow-up, months | 17.1±15.8 (5–51.9) | 8.1±3.1 (5.6–13.5) | 13.1±12.5 (5–51.9) | 0.16 |
| Occlusion grade | ||||
| Complete | 5 (56) | 4 (57) | 9 (56) | 1.00 |
| Entry remnant | 0 (0) | 1 (14) | 1 (6) | 0.44 |
| Subtotal filling | 3 (33) | 1 (14) | 4 (25) | 0.58 |
| Total filling | 1 (9) | 1 (14) | 2 (10) | 1.00 |
Data are presented as n (%), n (range), or mean ± SD (range). PED, Pipeline embolization device; DSA, digital subtraction angiography; VRD, vascular reconstruction device.